Table 1. Statistic analyses comparing N-glycans derived from 19 ALS patient sera and from 24 healthy candidate sera.
| Peak no. | Assignment | ANOVA (p Value) | Mann-Whitney (p Value) | Welch T-test (p Value) | Fold Change |
| 1 | A2 | 0.578 | 0.230 | 0.605 | −1.13 |
| 2 | Fc(6)A2 | 0.277 | 0.123 | 0.238 | −1.09 |
| 3 | Fc(6)A1G1 | 0.434 | 0.317 | 0.432 | −1.09 |
| 4 | Fc(6)A2G1 | 0.058 | 0.047 | 0.043 | −1.15 |
| Fc(6)A2BG1 | |||||
| Fc(6)M4A1G1 | |||||
| 5 | A2G2 | 0.118 | 0.063 | 0.140 | +1.83 |
| M6A1 | |||||
| 6 | Fc(6)A2G2 | 0.008 | 0.020 | 0.003 | −1.32 |
| Fc(6)A2BG2 | |||||
| Fc(6)M6A1 | |||||
| 7 | M7 | 0.480 | 0.511 | 0.550 | +1.12 |
| A2G2S1 | |||||
| Fc(6)A2G2S1 | |||||
| Fc(6)A2BG2S1 | |||||
| 8 | Fc(6)A2BG1S1 | 0.012 | 0.014 | 0.009 | −1.16 |
| A2G2S1 | |||||
| Fc(6)A2G2S1 | |||||
| 9 | M8 | 0.094 | 0.086 | 0.064 | +1.12 |
| Fc(6)A2G2S1 | |||||
| Fc(6)A2BG2S1 | |||||
| A2G2S2 | |||||
| 10 | A2G2S2 | 0.023 | 0.007 | 0.019 | +1.36 |
| Fc(6)A2G2S2 | |||||
| Fc(6)A2BG2S2 | |||||
| A2F1G2S1 | |||||
| A3G3S1 | |||||
| 11 | M9 | 0.039 | 0.079 | 0.024 | −1.53 |
| A3G3S1 | |||||
| A3BG3S1 | |||||
| A4G3S1 | |||||
| 12 | A3G3S2 | 0.257 | 0.193 | 0.262 | −1.22 |
| Fc(6)A3G3S1 | |||||
| A4G3S1 | |||||
| A3F1G3S1 | |||||
| 13 | A3G3S3 | 0.001 | 0.001 | 0.001 | +1.67 |
| Fc(6)A3G3S2 | |||||
| A4G3S2 | |||||
| A3F1G3S2 | |||||
| Fc(6)A3F1G3S1 |
Fold of change: (+) assigns that N-glycan amounts in ALS sera are higher relative to glycans from healthy candidate sera and (−) assigns the contrary.